The lotion, intended to treat skin conditions like eczema and psoriasis, represents Teligent’s sixth approval from its internally developed portfolio of topical generic drug products, according to a news release.
The company plans to launch the lotion in the first quarter of 2017.
More articles on supply chain:
Addiction centers pay more than $700k to resolve allegations of improper prescribing
Court orders contracted pilots for Amazon, DHL to return to work after strike
DEA bans furanyl fentanyl
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
